BioFarma

02/22/2019

Typhoid conjugate vaccine from Indonesia found to be safe, immunogenic in phase 1 clinical trial

    SEOUL, Korea, JAKARTA, Indonesia, February 22, 2019 — Scientists from Bio Farma, the University of Indonesia, and the International Vaccine Institute (IVI), recently published the results of a phase I clinical trial study of a novel typhoid conjugate vaccine involving Indonesian adults and […]